We observed that triple-negative breast cancers tended to have increased CDH13 methylation (p = 0.044) and a decreased methylation of the RASSF1A (p<0.02) and SFRP1 (p<0.05, Fig. 4a) genes when compared with other subtypes. The gene discussed is CDH13; the disease is triple-negative breast carcinoma.